Secretion of the amyloid precursor protein is elevated isoform specifically by apolipoprotein E4

  • L. Oron
  • M. Efrati
  • Daniel. M. Michaelson
Conference paper


Genetic studies suggest that the neuropathology and etiology of Alzheimer’s disease (AD) are associated with several genotypes including mutations in the amyloid precursor protein (APP) gene and the allele E4 of apolipoprotein E (apoE). The present study investigated the possibility that cross talk interactions exist between APP and apoE and the extent to which they are affected by the apoE genotype. This was pursued by cell culture and immunoblot experiments utilizing neuroblastoma N2a cells in which the effects of distinct apoE isoforms on the levels of intracellular APP and of secreted APPs were determined. This revealed that treatment of the cells with apoE4, the AD risk factor, resulted in a marked increase in the levels of secreted APPs. This effect was dose dependent (ED50 ≅ 2.5μg/ml) and isoform specific in that apoE3 had virtually no effect on the secretion of APPs.


Amyloid Precursor Protein apoE Genotype Human apoE3 Amyloid Precursor Protein Metabolism Alzheimer Amyloid Precursor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barger SW, Mattson MP (1997) Isoform specific modulation by apolipoprotein E of the activities of secreted β-amyloid precursor protein. J Neurochem 69: 60 – 67Google Scholar
  2. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 270: 27063 – 27071PubMedCrossRefGoogle Scholar
  3. Caporaso GL, Gandy SE, Buxbaum JP, Ramabhardan TV, Greengard P (1992) Protein phosphorylation regulates secretion of Alzheimer beta/A4 precursor protein. Proc Natl Acad Sci (USA) 89: 3055 – 3059CrossRefGoogle Scholar
  4. Corder EH, Saunders AM, Strittmater WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines IL, Pericak-Vance MA (1993) Gene dose of apolipoprotein-E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261: 921 – 923PubMedCrossRefGoogle Scholar
  5. Desdouits-Magnen J, Desdouites F, Takeda S, Syu L-J, Saltiel AR, Bouxbaum JD, Czernik AJ, Neiren AC, Griengard P (1998) Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J Neurochem 70: 524 – 530PubMedCrossRefGoogle Scholar
  6. Hass S, Fresser F, Kochl S, Beyreuther K, Utermann G, Baier G (1998) Physical interaction of apoE with amyloid precursor protein independent of the amyloid region in vitro. J Biol Chem 273: 13892 – 13897PubMedGoogle Scholar
  7. Hilbich C, Monning U, Grund C, Masters CL, Beyreuther K (1993) Amyloid-like properties of peptides flanking the epitope of anyloid precursor protein-specific monoclonal antibody 22C11. J Biol Chem 268: 26571 – 26577PubMedGoogle Scholar
  8. Levy-Lahad E, Wasco W, Poovkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette Y, Galas D, Nemens E, Wijman EM, Bird TD, Schellenberg GD, Tanzi RE (1995) Candidate gene for the chronosome L familial Alzheimer’s disease locus. Science 269: 973 – 977PubMedCrossRefGoogle Scholar
  9. Mhley RW (1988) Apolipoprotein E cholesterol transport protein with expanding role in cell biology. Science 240: 622 – 630Google Scholar
  10. Masters CL, Beyreuther K (1998) Alzheimer’s disease. Br Med J 316: 446 – 448Google Scholar
  11. Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14 (1): 55 – 61Google Scholar
  12. Muller W, Meske V, Berlin K, Scharnagl H, Marz H, Ohm TG (1998) Apolipoprotein E isoforms increase intracellular Ca2+ differentially through a ω-agatoxin IVa-sensitive Ca2+-channel. Brain Pathol 8: 641 – 653PubMedCrossRefGoogle Scholar
  13. Nitsch RM, Slack BE, Wutrman RJ, Growdon JA (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258: 304 – 307PubMedCrossRefGoogle Scholar
  14. Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Ann Rev Med 47: 387 - 400Google Scholar
  15. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Piricak-Vance MA, Joo SH, Rosi B A, Grisella JF, Crapper-Machachlan DR, Alpats MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein-E allele E4 with late onset familial sporadic Alzheimer’s disease. Neurology 43: 1467 – 1472PubMedGoogle Scholar
  16. Selkoe DS (1998) The cell biology of beta-amyloid precursor protein and presenilins in Alzheimer’s disease. Trends Cell Biol 8: 447 – 453PubMedCrossRefGoogle Scholar
  17. Sherrington R, Rogaeva EI, Liang Y, Rogaeva EA, Levesque E, Ikeda M, Chi H, Lin C, Li G, Holman K (1995) Cloning of a gene bearing missense mutations in early onset familial Alzheimer’s disease. Nature 375: 754 – 760PubMedCrossRefGoogle Scholar
  18. Slake BE, Nitsch RM, Livne E, Kunz GM, Eldar N, Wurtman RJ (1993) Regulation of amyloid precursor protein release by protein kinase C in Swiss 3T3 fibroblasts. Ann N Y Acad Sci 695: 128 – 131CrossRefGoogle Scholar
  19. Wolozin BL, Basaric-Keys J, Canter R, Li Y, Vanderputten D, Sunderland T (1996) Differential regulation of APP secretion in apolipoprotein E3 and E4. Ann N Y Acad Sci 777: 322 – 326PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2000

Authors and Affiliations

  • L. Oron
    • 1
  • M. Efrati
    • 1
  • Daniel. M. Michaelson
    • 2
  1. 1.Department of Neurobiochemistry, George S. Wise Faculty of Life SciencesTel Aviv UniversityTel AvivIsrael
  2. 2.Department of Neurobiochemistry, Faculty of Life SciencesTel Aviv UniversityTel AvivIsrael

Personalised recommendations